SK bioscience
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025 2025-11-05 21:00
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia 2025-10-15 20:00
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift 2025-09-02 19:00
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health 2025-08-21 20:00
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate 2025-07-17 19:00
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine 2025-05-21 20:00
SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats 2025-05-06 20:00
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate 2025-02-25 21:00
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate 2024-12-12 21:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 20:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 15:11
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions 2024-10-08 20:00
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika 2024-10-02 20:00
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center 2023-02-08 20:00
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs 2023-01-27 20:00
SK bioscience Appoints New Executives to Accelerate New Growth Strategies 2023-01-20 20:00
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia 2023-01-09 21:00
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
1 2